Archives

ATLANTA—Subcutaneous administration of the anti-CD 38 monoclonal antibody daratumumab could help more patients get this emerging therapy more easily for their advanced or recently-diagnosed multiple m

SOURCE: Pediatric Physical Therapy journal ARTICLE “Trends in Attitudes and Practice Patterns of Physical Therapists in Addressing Childhood Obesity in Schools”[url=http://journals.lww.com

Uptake of the Congenital Muscular Torticollis Guidelines Survey findings about the effectiveness of a recently-introduced clinical practice guideline for congenital muscular torticollis therapy are re

NEW YORK— A case series of two children with benign paroxysmal positional vertigo (BPPV) is reported in Pediatric Physical Therapy journal by Jennifer L. Fay, PT, DPT, NCS, Neurologic Clinical Special

MILAN, Italy—Genomic profiling could help reduce the risk of over-treatment in primary prostate cancer (PC) by identifying patients and healthy individuals whose genes put them at greatest risk of dev

MILAN, Italy—The first choice of therapy for patients with metastatic kidney cancer who have failed VEGF therapy has changed according to experts at the 2016 European Multidisciplinary Meeting

MILAN, Italy—Patients with node-positive prostate cancer being treated with prostatectomy could derive benefit from early multimodality therapy combining androgen deprivation therapy (ADT) with radiot

ARTICLE MILAN, Italy—Genomic testing combined with clinical assessment could be the best way to identify patients with prostate cancer who can benefit from early radiotherapy after prostatectomy, acco

April 15, 2017 Active Surveillance for Renal Cell Cancer MILAN, Italy—Criteria for withholding aggressive therapies early in the course of renal cell cancer were updated at the 2016 European Mu

Audio Journal of Oncology AMSTERDAM—Women diagnosed with ductal carcinoma in situ (DCIS) of the breast were found to live longer than women in the general population according to a study from the Neth

Hans Kristensen, Director of the Nuclear Information Project, Federation of American Scientists, Washington DC and co-author of “The Growing Threat of Nuclear War and the Role of the Health Comm

Audio Journal of Oncology, January 2, 2017 COPENHAGEN—Patients with metastatic non-small cell lung cancers (NSCLC) expressing the programmed cell-death ligand 1 (PD-L1) protein responded better to ini

COPENHAGEN—Longer progression free survival (PFS) was achieved in patients with ALK-rearranged non-small cell lung cancer (NSCLC) previously treated with crizotinib randomised to treatment with the se

The Audio Journal of Oncology Reporting from the 2016 Congress of the European Society of Medical Oncology COPENHAGEN—The anti-PD-L1 (programmed cell death ligand-1) immunotherapy agent atezolizumab e

COPENAGEN—Adding the PD-1 (programmed cell death protein 1) antibody pembrolizumab to standard first-line chemotherapy with carboplatin and pemetrexed for previously-untreated patients with advanced n

COPENHAGEN—In a phase I study reported at the 2016 congress of the European Society for Medical Oncology (ESMO) six out of 15 patients with resectable early non-small cell lung cancer had “major

Audio Journal of Oncology COPENHAGEN, Denmark—In a phase 1b study patients with previously untreated stage IV pancreatic cancer responded or derived “clinical benefit” from a regimen in wh

COPENHAGEN, Denmark—Marked prolongation of progression free survival (PFS) in all groups of patients with platinum-sensitive recurrent ovarian cancer was reported at the European Society for Medical O

DESCRIPTION COPENHAGEN, Denmark—The efficacy of endocrine therapy in breast cancer was improved—in the MONALEESA-2 study—by the addition of the cyclin-dependent kinase (CDK) 4/6 inhibitor ribociclib t

COPENHAGEN, Denmark—Checkpoint inhibition prolonged life when used as adjuvant therapy among patients with fully resected stage III malignant melanoma in the EORTC 18071 randomized phase III compariso

Side effects from early treatment of low and intermediate risk prostate cancer need to be balanced agains the new finding that mortality is no different during the first ten years irrespective of the

Active monitoring seems to be the safest and most comfortable option for most men with localised prostate cancer according to findings of the big randomised ProtecT study from the UK. Surgery and rad

The superiority of radiotherapy for treating Stage 2A testicular seminoma has been confirmed by a new study. Radiation should now be recommended to avoid present uncertainties—under which chemot

Data showing that whole brain radiotherapy should not be used in patients whose non-small cell lung cancer has metastasized to the brain were reported at the European Respiratory Society 2016 congress

Atrial fibrillation is prevented by exercise and life-long endurance athletes do not face the same elevated risks of stroke and heart disease from the condition as sedentary patients. Leisure and eve